{"favorite_id": 4017, "calc_type": "", "dosing": false, "full_title_en": "McMahon Score for Rhabdomyolysis", "short_title_en": "McMahon Score", "medium_description_en": "<span>Predicts mortality or acute kidney injury (AKI) in rhabdomyolysis patients.</span>", "short_description_en": "Rhabdo mortality.", "before_use": "", "instructions_en": "<p><span>Use in patients &ge;18 years old with rhabdomyolysis (<abbr title=\"Creatine phosphokinase\" style=\"color: #ffb600;\">CPK</abbr> &gt;5,000 U/L within 72 hours of admission). Do not use in patients with pre-existing end-stage renal disease or with elevated CPK due to MI.</span></p>", "purpose_en": ["Prognosis"], "disease_en": ["Renal Failure"], "specialty_en": ["Emergency Medicine", "Nephrology"], "chief_complaint_en": ["AMS", "Abdominal Pain", "Fever", "Vomiting"], "system_en": ["Renal"], "search_abbreviation_en": ["rhabdomylosis risk calculator", "rabdo", "Rhabdo"], "slug": "mcmahon-score-rhabdomyolysis", "seo": {"meta_description_en": "The Rhabdomyolysis Risk Score predicts mortality or acute kidney injury (AKI) in rhabdomyolysis patients.", "keywords_en": "Rhabdomyolysis, gearoid mcmahon, bwh, rhabdo, rabdo"}, "content": {"how_to_use": {"use_case_en": "<p><span id=\"docs-internal-guid-f8c992ab-ce4a-a14c-863b-84d1e21f4b98\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Patients &ge;18 years old with rhabdomyolysis (CPK&nbsp;&gt;5,000 U/L within 72 hours of admission).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Do not use in patients with pre-existing end-stage renal disease or elevated CPK due to MI.</p>\n</li>\n</ul>", "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-9fddc0ee-ce4b-9dd9-b979-c96c46265714\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Can be used in both traumatic and atraumatic rhabdomyolysis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Not validated for patients who have had renal replacement therapy (RRT) within 24 hours.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Not yet prospectively validated (has been <a href=\"https://ccforum.biomedcentral.com/articles/10.1186/cc14363\" target=\"_blank\">retrospectively validated</a>).</p>\n</li>\n</ul>", "why_use_en": "<p><span id=\"docs-internal-guid-5fb7b90f-ce4b-c372-5729-abe535f3a0a9\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Uses readily available clinical demographic and laboratory values.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">More specific than CPK alone at predicting need for RRT (<abbr title=\"Area under a ROC curve\">AUROC</abbr> 0.775 vs 0.631).</p>\n</li>\n</ul>"}, "next_steps": {"advice_en": "<p><span id=\"docs-internal-guid-05b91dc9-ce4b-ed48-575e-92c37c58784c\"></span></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">CPK &gt;1,000 U/L provides laboratory confirmation of the clinical diagnosis (CPK &gt;40,000 U/L is used as a risk factor in the score).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Delayed increase in CPK is&nbsp;common and therefore serial levels should be obtained.</p>\n</li>\n</ul>", "management_en": "<p><span id=\"docs-internal-guid-f3865245-ce4c-1353-1282-0dd438a041b9\">Renal protective therapy should include fluid resuscitation targeting euvolemia and urinary output of at least 1&ndash;2 mL/kg/hr.</span></p>", "critical_actions_en": "<p><span id=\"docs-internal-guid-b7795584-ce4c-30ce-a5d5-7876bb9f5fa0\">Renal protective therapies should be considered in all patients deemed to be at high risk (score &ge;6) irrespective of admission CPK.</span></p>"}, "about": {"formula_en": "<p><span>Addition of the selected points:</span></p>\n<div class=\"table-responsive\">\n<table class=\"table table-bordered\">\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>Variable</strong></p>\n</td>\n<td>\n<p><strong>Points</strong></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"4\">\n<p><span>Age, years</span></p>\n</td>\n<td>\n<p><span>&le;50</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>51&ndash;70</span></p>\n</td>\n<td>\n<p><span>1.5</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>71&ndash;80</span></p>\n</td>\n<td>\n<p><span>2.5</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>&gt;80</span></p>\n</td>\n<td>\n<p><span>3</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p><span>Sex</span></p>\n</td>\n<td>\n<p><span>Male</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Female</span></p>\n</td>\n<td>\n<p><span>1</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p><span>Initial creatinine</span></p>\n</td>\n<td>\n<p><span>&lt;1.4 mg/dL (124 &micro;mol/L)</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>1.4&ndash;2.2 mg/dL (124&ndash;195 &micro;mol/L)</span></p>\n</td>\n<td>\n<p><span>1.5</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>&gt;2.2 mg/dL (195 &micro;mol/L)</span></p>\n</td>\n<td>\n<p><span>3</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p><span>Initial calcium &lt;7.5 mg/dL (1.88 mmol/L)</span></p>\n</td>\n<td>\n<p><span>No</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Yes</span></p>\n</td>\n<td>\n<p><span>2</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p>Initial CPK&nbsp;&gt;40,000 U/L</p>\n</td>\n<td>\n<p><span>No</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Yes</span></p>\n</td>\n<td>\n<p><span>2</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p><span>Rhabdo secondary to seizures, syncope, exercise, statins, or myositis</span></p>\n</td>\n<td>\n<p><span>Yes</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>No</span></p>\n</td>\n<td>\n<p><span>3</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"3\">\n<p><span>Initial phosphate</span></p>\n</td>\n<td>\n<p><span>&lt;4.0 mg/dL (1.0 mmol/L)</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>4.0&ndash;5.4 mg/dL </span>(1.0-1.4 mmol/L)</p>\n</td>\n<td>\n<p><span>1.5</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>&gt;5.4 mg/dL</span>&nbsp;(1.4 mmol/L)</p>\n</td>\n<td>\n<p><span>3</span></p>\n</td>\n</tr>\n<tr>\n<td rowspan=\"2\">\n<p><span>Initial bicarbonate &lt;19 mEq/L (19 mmol/L)</span></p>\n</td>\n<td>\n<p><span>No</span></p>\n</td>\n<td>\n<p><span>0</span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><span>Yes</span></p>\n</td>\n<td>\n<p><span>2</span></p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"91\" /><col width=\"114\" /><col width=\"246\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>McMahon Score</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Risk group</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Recommendation</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&lt;6</p>\n</td>\n<td>\n<p dir=\"ltr\">Low risk</p>\n</td>\n<td>\n<p dir=\"ltr\">Usual care (3% risk of death or AKI requiring RRT)</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&ge;6*</p>\n</td>\n<td>\n<p dir=\"ltr\">Not low risk</p>\n</td>\n<td>\n<p dir=\"ltr\">Initiate renal protective therapy including high-volume fluid resuscitation to urine output 1-2 mL/kg/hr (52% risk of death or AKI requiring RRT at scores &ge;10)</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\">From <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27259093\" target=\"_blank\">Simpson 2016</a>.</p>\n<p dir=\"ltr\">*McMahon Score &ge;6, calculated on admission, is 86% sensitive and 68% specific for identifying patients who will require RRT.</p>", "evidence_based_medicine_en": "<p dir=\"ltr\"><strong>Derivation study</strong>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/24000014\" target=\"_blank\">McMahon 2013</a>.</p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Design</strong>:</p>\n<p dir=\"ltr\">Retrospective study in two teaching hospitals, n = 2,371.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Aim</strong>:</p>\n<p dir=\"ltr\">Derive and validate a risk prediction equation to estimate risk of <abbr title=\"Renal replacement therapy\">RRT</abbr> or death in patients with rhabdomyolysis.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Inclusion criteria</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Age &ge;18 years.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">CPK levels &gt;5,000 U/L within 72 hours of admission.</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Exclusion criteria</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Preexisting end-stage renal disease.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Patient receiving RRT for at least 24 hours.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">CPK elevation considered due to acute MI.</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Outcomes</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In-hospital mortality: 335 patients (14%).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">AKI: 1,081 patients (46%).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Need for RRT: 190 patients (8%).</p>\n</li>\n</ul>\n</ul>\n<p></p>\n<p dir=\"ltr\"><strong>Validation study</strong>, <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/27259093\" target=\"_blank\">Simpson 2016</a>.</p>\n<p></p>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Design</strong>:</p>\n<p dir=\"ltr\">Retrospective observational, n = 232.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Aims</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Identify CPK thresholds to guide clinical management.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Evaluate the prognostic performance of McMahon Score.</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Inclusion criteria</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Age &ge;18 years.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">CPK levels &gt; 1,000 U/L.</p>\n</li>\n</ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Exclusion criteria</strong>:</p>\n<p dir=\"ltr\">Not listed.</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Outcomes</strong>:</p>\n</li>\n<ul>\n<li dir=\"ltr\">\n<p dir=\"ltr\">In-hospital mortality: 86 (11%).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Acute renal failure: 45 patients (19%).</p>\n</li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Need for RRT: 29 patients (12.5%).</p>\n</li>\n</ul>\n</ul>", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/24000014 ", "text": "McMahon GM, Zeng X, Waikar SS. A risk prediction score for kidney failure or mortality in rhabdomyolysis. JAMA Intern Med. 2013;173(19):1821-8."}], "Other References": [], "Validation": [{"href": "https://ccforum.biomedcentral.com/articles/10.1186/cc14363", "text": "Simpson J, Taylor A, et al. Rhabdomyolysis: early prognostication of renal failure and other adverse outcomes. 35th International Symposium on Intensive Care and Emergency Medicine. Poster presentation. Critical Care. 2015;19(Suppl 1):P283"}], "Clinical Practice Guidelines": [], "Manufacturer Website": [], "Outcomes": []}}, "contributor": {"expert_name": [{"description": "<p>Elie Harmouche, MD, is a medical toxicology fellow at the department of emergency medicine at New York University. He was born and raised in Beirut, Lebanon, and he received his medical degree from the American University of Beirut. He completed a residency in emergency medicine at Henry Ford Hospital in Detroit, MI and served as chief resident in his final year, followed by fellowship in toxicology at NYU Langone/Bellevue Hospital Center in New York City. His areas of interest include toxicology, addiction and substance use, simulation medicine, resuscitation, and critical care.</p>", "firstName": "Elie", "img": "https://cdn-web-img.mdcalc.com/people/elie-harmouche.jpg", "lastName": "Harmouche", "name": "Elie Harmouche, MD", "target": "elie-harmouche", "signedCOI": false, "hasDisclosure": []}]}, "creator": [{"name": "Dr. Gearoid M. McMahon", "qa_en": "", "approved": true, "creator_info": {"about_en": "<p>Gearoid M. McMahon, MD, MB, BCh, is a nephrologist at Brigham and Women's Hospital in Boston. He is also one of the editors of the popular nephrology resource <a href='http://renalfellow.blogspot.com/' target='_blank'>Renal Fellow Network</a>. Dr. McMahon\u2019s research focuses primarily on acid-base disorders, acute renal failure, glomerular disease, and kidney stones.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-gearoid-m-mcmahon.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=McMahon+GM%5BAuthor%5D"}}], "reviewer": {"expert_name": []}, "related_resources": {"mdcalc_rating": [], "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "radio", "label_en": "Age, years", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "\u226450", "value": 0}, {"label": "51-70", "value": 1.5}, {"label": "71-80", "value": 2.5}, {"label": ">80", "value": 3}], "name": "age"}, {"type": "toggle", "label_en": "Sex", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Male", "value": 0}, {"label": "Female", "value": 1}], "name": "sex"}, {"type": "radio", "label_en": "Initial creatinine", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": true, "options": [{"label": "<1.4 mg/dL (124 \u00b5mol/L)", "value": 0}, {"label": "1.4\u20132.2 mg/dL (124\u2013195 \u00b5mol/L)", "value": 1.5}, {"label": ">2.2 mg/dL (195 \u00b5mol/L)", "value": 3}], "name": "cre"}, {"type": "toggle", "label_en": "Initial calcium <7.5 mg/dL (1.88 mmol/L)", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "ca"}, {"type": "toggle", "label_en": "Initial CPK >40,000 U/L", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "cpk"}, {"type": "toggle", "label_en": "Rhabdo secondary to seizures, syncope, exercise, statins, or myositis", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "Yes", "value": 0}, {"label": "No", "value": 3}], "name": "rhabdo"}, {"type": "radio", "label_en": "Initial phosphate", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "<4.0 mg/dL (1.0 mmol/L)", "value": 0}, {"label": "4.0\u20135.4 mg/dL (1.0-1.4 mmol/L)", "value": 1.5}, {"label": ">5.4 mg/dL (1.4 mmol/L)", "value": 3}], "name": "phos"}, {"type": "toggle", "label_en": "Initial bicarbonate <19 mEq/L (19 mmol/L)", "default": 0, "conditionality": "", "show_points": true, "tips_en": "", "optional": false, "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "name": "bicarb"}], "md5": "", "cmeVersion": "4017.1", "related_calcs": [{"calcId": 10063, "short_title_en": "Licurse Score", "slug": "licurse-score-renal-ultrasound"}, {"calcId": 10045, "short_title_en": "Kidney Failure Risk Calculator", "slug": "kidney-failure-risk-calculator"}, {"calcId": 691, "short_title_en": "SOFA Score", "slug": "sequential-organ-failure-assessment-sofa-score"}]}